SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves selloff is being discussed alongside concerns about its heavy debt load, rising borrowing costs and whether AI demand and contract backlog can support its financing needs, with HSBCs bearish assessment adding to the pressure. Traders are split between viewing the balance-sheet risks and insider selling as reasons for further downside and arguing that strong demand, the backlog and Nvidia ties make the drop a buying opportunity.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders react to elevated crude prices and fears that Middle East shipping or energy-infrastructure attacks could disrupt supply, while weighing possible diplomacy and Russian supply relief. The community is split between bulls focused on geopolitical risk and bears expecting the risk premium to fade, with some also warning that contract-roll effects and an extended run may amplify volatility.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lilly is drawing attention after breaking to a new high, with traders linking the rally to European regulatory backing for its Foundayo obesity pill and broader optimism about its GLP-1 business. Bulls are celebrating the breakout and healthcares defensive appeal, while skeptics point to possible profit-taking, competition from Novo and the upcoming earnings report.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is fueling a heavily bearish conversation, with traders tying its political-proxy appeal to concerns about Trumps approval and the midterms, while questioning the companys business traction. A smaller bullish contingent sees a possible trading bounce and points to the pending TAE fusion deal as a potential pivot.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers rebound toward a one-year high and the $30 level is driving discussion, with traders focused on whether the move can break through resistance. Some see momentum from a defensive-sector rotation and pipeline developments ahead of earnings, while others say the stock needs stronger news to sustain a breakout.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, drawing attention to the drugs potential but also to concerns about modest symptom improvement, agitation-related side effects, and discontinuations. Traders are divided, with some viewing the move as a fading bounce and adding shorts while others point to bullish analyst commentary.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicor is drawing attention after strong Q3 results and an upbeat outlook, with AI-related demand and growing Vertical Power Delivery royalty revenue reinforcing the growth story. Traders are weighing that strength against questions about one-time royalty catch-up payments, production capacity, and the earnings-per-share miss, contributing to a volatile reaction.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is caught in a sharp selloff across AI infrastructure and neocloud stocks as investors question whether heavy data-center spending and financing risks will generate adequate returns, with Gartners warning adding to the concern. Traders disagree on whether the pressure signals more downside or an oversold opportunity, with bulls pointing to IRENs contracted demand, power assets, and managements financing reassurances.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention for a sharp rebound after a tech-led selloff, which traders link to unconfirmed reports of potential U.S.-Iran talks and easing oil prices. The community is split between viewing the move as a bullish reversal and warning it may be a bull trap amid persistent volatility and concerns about tech and AI stocks.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

A semiconductor rebound after a prolonged selloff is driving attention, with traders debating whether the move signals a durable bottom or a temporary bounce amid lingering concerns about AI spending and valuations. Chip gains are part of a broader technology recovery ahead of major tech earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SPHR Stock Slapped With Downgrade As 'Wizard Of Oz' Interest Cools, But Retail Is 'Extremely Bullish'

Equity

Despite a sharp stock drop, retail sentiment around Sphere Entertainment has improved. 


MSGS Stock Hits Record High As Board Backs Plan To Spin Off Knicks, Rangers Franchises

The company said its board unanimously approved a plan to explore a spin-off of its New York Knicks and New York Rangers businesses into two separately traded public companies.

Gabelli ETFs Trust - Gabelli Opportunities in Live and Sports ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Craig-Hallum downgraded Sphere Entertainment to Hold and cut its price target to $132 from $170.</li><li>Sphere said “Wizard of Oz” has generated over $500 million in ticket sales.</li><li>Sphere Entertainment’s Q2 revenue rose 11% to $313.6 million, but losses widened.&nbsp;&nbsp;</li></ul>Shares of Sphere Entertainment Co. (SPHR) tumbled nearly 14% on Monday, their worst day in over a year, after a Wall Street analyst downgraded the stock and said demand for one of the venue's major flagship experiential productions is cooling faster than expected.<a href="https://stocktwits.com/symbol/SPHR">Sphere Entertainment stock</a> closed at $110.80 and inched up 0.6% in overnight trading.<h2 class="st-heading-2">Craig-Hallum Sees No Meaningful Demand Increase At Sphere</h2>Craig-Hallum analyst Ryan Sigdahl downgraded Sphere Entertainment to 'hold' from 'buy,'&nbsp;according to a summary of the note on The Fly, and lowered his price target to $132 from $170, citing "faster-than-expected" weakening in demand for “The Wizard of Oz”.&nbsp;The new target still implies 19% upside from Monday's close.Sigdahl said recent numbers show the updated version of the show, released Sept. 25, has not meaningfully increased demand. He also plans to cut his financial estimates, citing deteriorating demand trends.The update added 4D effects including moving Winged Monkeys, scents, fireworks, and "Glinda Glitter." The show has been running in Las Vegas since Aug. 28, 2025.Last month, Sphere said the attraction has generated more than $500 million in ticket sales, with more than 4 million tickets sold since its debut.According to multiple reports, tickets for “The Wizard of Oz” at Sphere in Las Vegas generally range from $96 to $349 depending on your seat location, package tier, and showtime.<h2 class="st-heading-2">Higher Costs Weigh On Sphere Entertainment’s Profit&nbsp;</h2>Sphere reported fiscal second-quarter revenue of $313.6 million&nbsp;in August, up 11% from a year earlier. Its operating loss widened to $61.3 million from $50.2 million, and adjusted operating income declined 17% to $50.9 million. The loss per share was $1.07.Revenue from the Sphere business climbed 29% to $226.4 million. The increase was largely driven by higher revenue from “The Wizard of Oz,” which recorded 220 performances during the quarter.&nbsp;Higher revenue came with increased costs. Sphere-related operating expenses rose 15%, while selling, general and administrative expenses increased 30%. Sphere Entertainment stock has been posting monthly losses since July.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261005_094840952_72de08f2a3.png" alt="koyfin_20261005_094840952.png" width="2400" height="1240"></figure><h2 class="st-heading-2">What SPHR Retail Traders Are Saying&nbsp;</h2>On Stocktwits, retail sentiment for SPHR improved to ‘extremely bullish’ from ‘bullish’ the previous day. Message volume has surged 700% over the past year, with a 13.7% gain in watchers.American heavy metal band Metallica is performing a 24-show concert residency, “Life Burns Faster,” at the Sphere in Las Vegas from Oct. 1, 2026, through March 13, 2027. According<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.rollingstone.com/music/music-live-reviews/metallica-life-burns-faster-sphere-review-1235630290/">&nbsp;to</a> Rolling Stone magazine, tickets for the shows have "sold out quickly," making SPHR retail traders even more bullish.One user&nbsp;<a href="https://stocktwits.com/v92/message/665802534">said</a>, “Metallica tickets are going for $2,000 each. &nbsp; Yeah. Go ahead and short this.”Another user&nbsp;<a href="https://stocktwits.com/DRMANHATTAN_/message/665798839">said</a>, “24% of the float is short at only around 35 million shares, primed for squeeze.”SPHR stock&nbsp;has fallen every month since July but has gained more than 16% year to date,&nbsp;maintaining&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-midcap-sphr-stock-is-outperforming-nflx-wbd-dis-in-2026/cZBNhUBRe2S">its lead</a> over entertainment peers such as Netflix, Warner Bros. Discovery and Disney.Also see:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvax-stock-outruns-moderna-as-vaxcyte-s-shot-clears-a-late-stage-test/cZDqXlfRBjM">NVAX Stock Outruns Moderna As Vaxcyte’s Shot Clears A Late-Stage Test</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

An advertisement for Wizard of Oz at Sphere is displayed on the Sphere.

Shares of Sphere Entertainment Co. (SPHR) tumbled nearly 14% on Monday, their worst day in over a year, after a Wall Street analyst downgraded the stock and said demand for one of the venue's major flagship experiential productions is cooling faster than 

Sphere Entertainment Co

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Feed

News

Sentiment

Fundamentals

Info

GOLS Gabelli ETFs Trust - Gabelli Opportunities in Live and Sports ETF

Fundamentals

Latest GOLS News